Skip to main content
. Author manuscript; available in PMC: 2018 Apr 20.
Published in final edited form as: J Mol Biomark Diagn. 2017 Feb 8;8(2):323. doi: 10.4172/2155-9929.1000323

Figure 2. Predicted probability distributions plotted for each ROC analysis.

Figure 2

1A) Distribution of predicted probabilities for patients with or without PrCa. 1B) Distribution of predicted probabilities for patients with high Gleason score (GS ≥ 7) disease. 1C) Distribution of predicted probabilities for patients with Gleason score ≤ 6. 1D) Distribution of predicted probabilities for patients with benign prostatic hyperplasia or PrCa.